• OPEN AN ACCOUNT
Indian Indices
Sensex
76,806.52 653.66
( 0.86%)
Global Indices
Nasdaq
53,682.77 599.82
(1.13%)
Dow Jones
7,765.55 77.95
(1.01%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.73 -0.22
(-0.23%)
EUR-INR
109.71 -0.40
(-0.36%)
GBP-INR
127.83 -0.65
(-0.50%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Supriya Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543434
INE07RO01027
148.8189477
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUPRIYA
34.13
6781.48
EPS(TTM)
Face Value()
Div & Yield %
24.69
2
0.12
 

Blue Star consolidated net profit rises 17.25% in the March 2026 quarter
May 06,2026
Net profit of Blue Star rose 17.25% to Rs 227.05 crore in the quarter ended March 2026 as against Rs 193.64 crore during the previous quarter ended March 2025. Sales rose 1.32% to Rs 4072.06 crore in the quarter ended March 2026 as against Rs 4018.96 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.75% to Rs 527.68 crore in the year ended March 2026 as against Rs 591.24 crore during the previous year ended March 2025. Sales rose 3.63% to Rs 12401.99 crore in the year ended March 2026 as against Rs 11967.65 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4072.064018.96 1 12401.9911967.65 4
OPM %8.016.94 -7.507.31 -
PBDT330.80284.24 16 920.73900.79 2
PBT282.57248.82 14 741.94772.42 -4
NP227.05193.64 17 527.68591.24 -11